EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder

Elizabeth Blank, Donald L Gilbert, Steve W Wu, Travis Larsh, Rana Elmaghraby, Rui Liu, Elizabeth Smith, Grace Westerkamp, Yanchen Liu, Paul S Horn, Ethan Greenstein, John A Sweeney und 2 weitere

Journal of Autism and Developmental Disorders · 2025-03 · 55 (3) · 940-954

DOI: 10.1007/s10803-024-06244-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Autism and Developmental Disorders, online erschienen am 15.05.2024. Verfasst von Elizabeth Blank und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Autism Spectrum Disorder, Major Depressive Disorder, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cincinnati Children's Research Foundation, Cincinnati Children’s Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Major depressive disorder (MDD) disproportionately affects those living with autism spectrum disorder (ASD) and is associated with significant impairment and treatment recidivism.

Methods

We studied the use of accelerated theta burst stimulation (ATBS) for the treatment of refractory MDD in ASD (3 treatments daily x 10 days). This prospective open-label 12-week trial included 10 subjects with a mean age of 21.5 years, randomized to receive unilateral or bilateral stimulation of the dorsolateral prefrontal cortex.

Results

One participant dropped out of the study due to intolerability. In both treatment arms, depressive symptoms, scored on the Hamilton Depression Rating Scale scores, diminished substantially. At 12 weeks post-treatment, full remission was sustained in 5 subjects and partial remission in 3 subjects. Treatment with ATBS, regardless of the site of stimulation, was associated with a significant, substantial, and sustained improvement in depressive symptomatology via the primary outcome measure, the Hamilton Depression Rating Scale. Additional secondary measures, including self-report depression scales, fluid cognition, and sleep quality, also showed significant improvement. No serious adverse events occurred during the study. Mild transient headaches were infrequently reported, which are expected side effects of ATBS.

Conclusion

Overall, ATBS treatment was highly effective and well-tolerated in individuals with ASD and co-occurring MDD. The findings support the need for a larger, sham-controlled randomized controlled trial to further evaluate efficacy of ATBS in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcranial Magnetic StimulationAutism Spectrum DisorderMajor Depressive DisorderDepressive Disorder, Treatment-ResistantHumansMaleFemaleTreatment OutcomeYoung AdultAdultAdolescentProspective StudiesTheta RhythmPsychiatric Status Rating ScalesDorsolateral Prefrontal CortexPrefrontal Cortex

Stichwörter der Autor:innen

AutismBrain StimulationDepressionFluid cognitionNeuromodulationTranscranial Magnetic Stimulation

Autor:innen und Institutionen

  • Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
  • Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
  • Division of Behavioral Medicine and Child Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
  • Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
  • Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. ernest.pedapati@cchmc.org.
  • Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. ernest.pedapati@cchmc.org.

Förderung

  • Cincinnati Children's Research Foundation
  • Cincinnati Children’s Research Foundation

Zitieren

APA

Blank, E., Gilbert, D. L., Wu, S. W., Larsh, T., Elmaghraby, R., Liu, R., Smith, E., Westerkamp, G., Liu, Y., Horn, P. S., Greenstein, E., Sweeney, J. A., Erickson, C. A., & Pedapati, E. V. (2025). Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders, 55(3), 940-954. https://doi.org/10.1007/s10803-024-06244-2

Vancouver

Blank E, Gilbert DL, Wu SW, Larsh T, Elmaghraby R, Liu R, et al. Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025;55(3):940-954. doi:10.1007/s10803-024-06244-2

BibTeX
@article{Blank2025,
  author = {Blank, Elizabeth and Gilbert, Donald L and Wu, Steve W and Larsh, Travis and Elmaghraby, Rana and Liu, Rui and Smith, Elizabeth and Westerkamp, Grace and Liu, Yanchen and Horn, Paul S and Greenstein, Ethan and Sweeney, John A and Erickson, Craig A and Pedapati, Ernest V},
  title = {Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder},
  journal = {Journal of Autism and Developmental Disorders},
  year = {2025},
  volume = {55},
  number = {3},
  pages = {940--954},
  doi = {10.1007/s10803-024-06244-2}
}
Kostenlos starten →